Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Allergy and Atopic Diseases: An Update on Experimental Evidence.

Verschoor D, von Gunten S.

Int Arch Allergy Immunol. 2019 Nov 6:1-9. doi: 10.1159/000504439. [Epub ahead of print] Review.

2.

The architecture of the IgG anti-carbohydrate repertoire in primary antibody deficiencies (PADs).

Jandus P, Frias Boligan K, Smith DF, de Graauw E, Grimbacher B, Jandus C, Abdelhafez MM, Despont A, Bovin N, Simon D, Rieben R, Simon HU, Cummings RD, von Gunten S.

Blood. 2019 Sep 19. pii: blood.2019001705. doi: 10.1182/blood.2019001705. [Epub ahead of print]

PMID:
31537530
3.

Antitumor effects of the GM3(Neu5Gc) ganglioside-specific humanized antibody 14F7hT against Cmah-transfected cancer cells.

Dorvignit D, Boligan KF, Relova-Hernández E, Clavell M, López A, Labrada M, Simon HU, López-Requena A, Mesa C, von Gunten S.

Sci Rep. 2019 Jul 9;9(1):9921. doi: 10.1038/s41598-019-46148-1.

4.

Differential Recognition of Diet-Derived Neu5Gc-Neoantigens on Glycan Microarrays by Carbohydrate-Specific Pooled Human IgG and IgA Antibodies.

Leviatan Ben-Arye S, Schneider C, Yu H, Bashir S, Chen X, von Gunten S, Padler-Karavani V.

Bioconjug Chem. 2019 May 15;30(5):1565-1574. doi: 10.1021/acs.bioconjchem.9b00273. Epub 2019 Apr 24.

PMID:
30994337
5.

Siglec-9 Regulates an Effector Memory CD8+ T-cell Subset That Congregates in the Melanoma Tumor Microenvironment.

Haas Q, Boligan KF, Jandus C, Schneider C, Simillion C, Stanczak MA, Haubitz M, Seyed Jafari SM, Zippelius A, Baerlocher GM, Läubli H, Hunger RE, Romero P, Simon HU, von Gunten S.

Cancer Immunol Res. 2019 May;7(5):707-718. doi: 10.1158/2326-6066.CIR-18-0505. Epub 2019 Apr 15.

PMID:
30988027
6.

Granulocyte death mediated by specific antibodies in intravenous immunoglobulin (IVIG).

Graeter S, Simon HU, von Gunten S.

Pharmacol Res. 2019 Feb 6:104168. doi: 10.1016/j.phrs.2019.02.007. [Epub ahead of print] Review.

PMID:
30738127
7.

Evaluation of Radiolabeled Girentuximab In Vitro and In Vivo.

Basaco T, Pektor S, Bermudez JM, Meneses N, Heller M, Galván JA, Boligán KF, Schürch S, von Gunten S, Türler A, Miederer M.

Pharmaceuticals (Basel). 2018 Nov 28;11(4). pii: E132. doi: 10.3390/ph11040132.

8.

Recent Advances in Experimental Allergy.

Adams OJ, von Gunten S.

Int Arch Allergy Immunol. 2018;177(4):281-289. doi: 10.1159/000494440. Epub 2018 Nov 13. Review.

9.

Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells.

Stanczak MA, Siddiqui SS, Trefny MP, Thommen DS, Boligan KF, von Gunten S, Tzankov A, Tietze L, Lardinois D, Heinzelmann-Schwarz V, von Bergwelt-Baildon M, Zhang W, Lenz HJ, Han Y, Amos CI, Syedbasha M, Egli A, Stenner F, Speiser DE, Varki A, Zippelius A, Läubli H.

J Clin Invest. 2018 Nov 1;128(11):4912-4923. doi: 10.1172/JCI120612. Epub 2018 Sep 24.

10.

A Cartography of Siglecs and Sialyltransferases in Gynecologic Malignancies: Is There a Road Towards a Sweet Future?

Haas Q, Simillion C, von Gunten S.

Front Oncol. 2018 Mar 13;8:68. doi: 10.3389/fonc.2018.00068. eCollection 2018.

11.

Targeting sialic acid-Siglec interactions to reverse immune suppression in cancer.

Adams OJ, Stanczak MA, von Gunten S, Läubli H.

Glycobiology. 2018 Sep 1;28(9):640-647. doi: 10.1093/glycob/cwx108. Review.

PMID:
29309569
12.

Isolation of Antibodies from Human Plasma, Saliva, Breast Milk, and Gastrointestinal Fluid.

Schneider C, Illi M, Lötscher M, Wehrli M, von Gunten S.

Methods Mol Biol. 2017;1643:23-31. doi: 10.1007/978-1-4939-7180-0_3.

PMID:
28667527
13.

IVIG regulates the survival of human but not mouse neutrophils.

Schneider C, Wicki S, Graeter S, Timcheva TM, Keller CW, Quast I, Leontyev D, Djoumerska-Alexieva IK, Käsermann F, Jakob SM, Dimitrova PA, Branch DR, Cummings RD, Lünemann JD, Kaufmann T, Simon HU, von Gunten S.

Sci Rep. 2017 May 2;7(1):1296. doi: 10.1038/s41598-017-01404-0.

14.

The Potential Use of Pharmacological Agents to Modulate Orthodontic Tooth Movement (OTM).

Kouskoura T, Katsaros C, von Gunten S.

Front Physiol. 2017 Feb 8;8:67. doi: 10.3389/fphys.2017.00067. eCollection 2017. Review.

15.

Innate lymphoid cells in asthma: cannabinoids on the balance.

Boligan KF, von Gunten S.

Allergy. 2017 Jun;72(6):839-841. doi: 10.1111/all.13145. No abstract available.

PMID:
28226397
16.

Antibody repertoire profiling with mimotope arrays.

Pashova S, Schneider C, von Gunten S, Pashov A.

Hum Vaccin Immunother. 2017 Feb;13(2):314-322. doi: 10.1080/21645515.2017.1264786. Epub 2016 Dec 8.

17.

Synchrotron microbeam irradiation induces neutrophil infiltration, thrombocyte attachment and selective vascular damage in vivo.

Brönnimann D, Bouchet A, Schneider C, Potez M, Serduc R, Bräuer-Krisch E, Graber W, von Gunten S, Laissue JA, Djonov V.

Sci Rep. 2016 Sep 19;6:33601. doi: 10.1038/srep33601.

18.

Clinical Use and Therapeutic Potential of IVIG/SCIG, Plasma-Derived IgA or IgM, and Other Alternative Immunoglobulin Preparations.

Späth PJ, Schneider C, von Gunten S.

Arch Immunol Ther Exp (Warsz). 2017 Jun;65(3):215-231. doi: 10.1007/s00005-016-0422-x. Epub 2016 Sep 16. Review.

PMID:
27638480
19.

Protection from experimental autoimmune encephalomyelitis by polyclonal IgG requires adjuvant-induced inflammation.

Quast I, Keller CW, Weber P, Schneider C, von Gunten S, Lünemann JD.

J Neuroinflammation. 2016 Feb 18;13:42. doi: 10.1186/s12974-016-0506-x.

20.

Intravenous Immunoglobulin with Enhanced Polyspecificity Improves Survival in Experimental Sepsis and Aseptic Systemic Inflammatory Response Syndromes.

Djoumerska-Alexieva I, Roumenina L, Pashov A, Dimitrov J, Hadzhieva M, Lindig S, Voynova E, Dimitrova P, Ivanovska N, Bockmeyer C, Stefanova Z, Fitting C, Bläss M, Claus R, von Gunten S, Kaveri S, Cavaillon JM, Bauer M, Vassilev T.

Mol Med. 2016 Apr;21(1):1002-1010. doi: 10.2119/molmed.2014.00224. Epub 2016 Mar 31.

21.

Longevity of implantable cardioverter defibrillators: a comparison among manufacturers and over time.

von Gunten S, Schaer BA, Yap SC, Szili-Torok T, Kühne M, Sticherling C, Osswald S, Theuns DA.

Europace. 2016 May;18(5):710-7. doi: 10.1093/europace/euv296. Epub 2015 Nov 25.

22.

MicroRNA-155: microtuning the allergic concert.

Cortinas-Elizondo F, von Gunten S.

Allergy. 2015 Sep;70(9):1035-6. doi: 10.1111/all.12673. No abstract available.

PMID:
26072940
23.

Basophils exhibit antibacterial activity through extracellular trap formation.

Yousefi S, Morshed M, Amini P, Stojkov D, Simon D, von Gunten S, Kaufmann T, Simon HU.

Allergy. 2015 Sep;70(9):1184-8. doi: 10.1111/all.12662. Epub 2015 Jun 18.

PMID:
26043360
24.

The human IgG anti-carbohydrate repertoire exhibits a universal architecture and contains specificity for microbial attachment sites.

Schneider C, Smith DF, Cummings RD, Boligan KF, Hamilton RG, Bochner BS, Miescher S, Simon HU, Pashov A, Vassilev T, von Gunten S.

Sci Transl Med. 2015 Jan 7;7(269):269ra1. doi: 10.1126/scitranslmed.3010524.

25.

Protein-glycan interactions as targets of intravenous/subcutaneous immunoglobulin (IVIg/SCIg) preparations.

von Gunten S.

Clin Exp Immunol. 2014 Dec;178 Suppl 1:151-2. doi: 10.1111/cei.12550. No abstract available.

26.

Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense.

Boligan KF, Mesa C, Fernandez LE, von Gunten S.

Cell Mol Life Sci. 2015 Apr;72(7):1231-48. doi: 10.1007/s00018-014-1799-5. Epub 2014 Dec 7. Review.

PMID:
25487607
27.

Human IgA Fc receptor FcαRI (CD89) triggers different forms of neutrophil death depending on the inflammatory microenvironment.

Wehrli M, Cortinas-Elizondo F, Hlushchuk R, Daudel F, Villiger PM, Miescher S, Zuercher AW, Djonov V, Simon HU, von Gunten S.

J Immunol. 2014 Dec 1;193(11):5649-59. doi: 10.4049/jimmunol.1400028. Epub 2014 Oct 22.

28.

Microbial glycan microarrays define key features of host-microbial interactions.

Stowell SR, Arthur CM, McBride R, Berger O, Razi N, Heimburg-Molinaro J, Rodrigues LC, Gourdine JP, Noll AJ, von Gunten S, Smith DF, Knirel YA, Paulson JC, Cummings RD.

Nat Chem Biol. 2014 Jun;10(6):470-6. doi: 10.1038/nchembio.1525. Epub 2014 May 11.

29.

IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientist.

von Gunten S, Shoenfeld Y, Blank M, Branch DR, Vassilev T, Käsermann F, Bayry J, Kaveri S, Simon HU.

Nat Rev Immunol. 2014 May;14(5):349. doi: 10.1038/nri3401-c1. No abstract available.

PMID:
24762829
30.

Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance.

Jandus C, Boligan KF, Chijioke O, Liu H, Dahlhaus M, Démoulins T, Schneider C, Wehrli M, Hunger RE, Baerlocher GM, Simon HU, Romero P, Münz C, von Gunten S.

J Clin Invest. 2014 Apr;124(4):1810-20. doi: 10.1172/JCI65899. Epub 2014 Feb 24.

31.

Mechanisms and potential therapeutic targets in allergic inflammation: recent insights.

von Gunten S, Cortinas-Elizondo F, Kollarik M, Beisswenger C, Lepper PM.

Allergy. 2013 Dec;68(12):1487-98. doi: 10.1111/all.12312. Epub 2013 Nov 12. Review.

PMID:
24215555
32.

Cell death in immune thrombocytopenia: novel insights and perspectives.

von Gunten S, Wehrli M, Simon HU.

Semin Hematol. 2013 Jan;50 Suppl 1:S109-15. doi: 10.1053/j.seminhematol.2013.03.016. Review.

33.

Alginate-coated chitosan nanogel capacity to modulate the effect of TLR ligands on blood dendritic cells.

Démoulins T, Bassi I, Thomann-Harwood L, Jandus C, Kaeuper P, Simon HU, von Gunten S, McCullough KC.

Nanomedicine. 2013 Aug;9(6):806-17. doi: 10.1016/j.nano.2013.01.002. Epub 2013 Jan 22.

PMID:
23347894
34.

Update in clinical allergy and immunology.

von Gunten S, Marsland BJ, von Garnier C, Simon D.

Allergy. 2012 Dec;67(12):1491-500. doi: 10.1111/all.12067. Epub 2012 Oct 30. Review.

PMID:
23110377
35.

Granulocyte death regulation by naturally occurring autoantibodies.

von Gunten S, Simon HU.

Adv Exp Med Biol. 2012;750:157-72. doi: 10.1007/978-1-4614-3461-0_12.

PMID:
22903673
36.

Glucocorticoids 'on air'.

von Gunten S, Kaufmann T.

Allergy. 2012 Feb;67(2):144-6. doi: 10.1111/j.1398-9995.2011.02778.x. No abstract available.

PMID:
22235794
37.

A differential concentration-dependent effect of IVIg on neutrophil functions: relevance for anti-microbial and anti-inflammatory mechanisms.

Casulli S, Topçu S, Fattoum L, von Gunten S, Simon HU, Teillaud JL, Bayry J, Kaveri SV, Elbim C.

PLoS One. 2011;6(10):e26469. doi: 10.1371/journal.pone.0026469. Epub 2011 Oct 31.

38.

Antibodies recognising sulfated carbohydrates are prevalent in systemic sclerosis and associated with pulmonary vascular disease.

Grader-Beck T, Boin F, von Gunten S, Smith D, Rosen A, Bochner BS.

Ann Rheum Dis. 2011 Dec;70(12):2218-24. doi: 10.1136/ard.2011.153130. Epub 2011 Aug 26.

39.

Glycomic analysis of human mast cells, eosinophils and basophils.

North SJ, von Gunten S, Antonopoulos A, Trollope A, MacGlashan DW Jr, Jang-Lee J, Dell A, Metcalfe DD, Kirshenbaum AS, Bochner BS, Haslam SM.

Glycobiology. 2012 Jan;22(1):12-22. doi: 10.1093/glycob/cwr089. Epub 2011 Jul 1.

40.

Targeting siglecs--a novel pharmacological strategy for immuno- and glycotherapy.

Jandus C, Simon HU, von Gunten S.

Biochem Pharmacol. 2011 Aug 15;82(4):323-32. doi: 10.1016/j.bcp.2011.05.018. Epub 2011 May 31. Review.

PMID:
21658374
41.

Dimeric IVIG contains natural anti-Siglec-9 autoantibodies and their anti-idiotypes.

Schaub A, von Gunten S, Vogel M, Wymann S, Rüegsegger M, Stadler BM, Spycher M, Simon HU, Miescher S.

Allergy. 2011 Aug;66(8):1030-7. doi: 10.1111/j.1398-9995.2011.02579.x. Epub 2011 Mar 9.

PMID:
21385183
42.

Cell death modulation by intravenous immunoglobulin.

von Gunten S, Simon HU.

J Clin Immunol. 2010 May;30 Suppl 1:S24-30. doi: 10.1007/s10875-010-9411-8. Review.

43.

Intravenous immunoglobulin contains a broad repertoire of anticarbohydrate antibodies that is not restricted to the IgG2 subclass.

von Gunten S, Smith DF, Cummings RD, Riedel S, Miescher S, Schaub A, Hamilton RG, Bochner BS.

J Allergy Clin Immunol. 2009 Jun;123(6):1268-76.e15. doi: 10.1016/j.jaci.2009.03.013. Epub 2009 May 13.

44.

Different patterns of Siglec-9-mediated neutrophil death responses in septic shock.

von Gunten S, Jakob SM, Geering B, Takala J, Simon HU.

Shock. 2009 Oct;32(4):386-92. doi: 10.1097/SHK.0b013e3181a1bc98.

PMID:
19295491
45.

Basic and clinical immunology of Siglecs.

von Gunten S, Bochner BS.

Ann N Y Acad Sci. 2008 Nov;1143:61-82. doi: 10.1196/annals.1443.011. Review.

46.

Natural anti-Siglec autoantibodies mediate potential immunoregulatory mechanisms: implications for the clinical use of intravenous immunoglobulins (IVIg).

von Gunten S, Simon HU.

Autoimmun Rev. 2008 Jun;7(6):453-6. doi: 10.1016/j.autrev.2008.03.015. Epub 2008 Apr 18. Review.

PMID:
18558361
47.

Inhibition of FcepsilonRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement.

Yokoi H, Choi OH, Hubbard W, Lee HS, Canning BJ, Lee HH, Ryu SD, von Gunten S, Bickel CA, Hudson SA, Macglashan DW Jr, Bochner BS.

J Allergy Clin Immunol. 2008 Feb;121(2):499-505.e1. Epub 2007 Nov 26.

PMID:
18036650
48.

Intravenous immunoglobulin preparations contain anti-Siglec-8 autoantibodies.

von Gunten S, Vogel M, Schaub A, Stadler BM, Miescher S, Crocker PR, Simon HU.

J Allergy Clin Immunol. 2007 Apr;119(4):1005-11. Epub 2007 Mar 2.

PMID:
17337295
49.

Autophagic-like cell death in neutrophils induced by autoantibodies.

von Gunten S, Simon HU.

Autophagy. 2007 Jan-Feb;3(1):67-8. Epub 2007 Jan 27. Review.

PMID:
17102587
50.

Immunologic and functional evidence for anti-Siglec-9 autoantibodies in intravenous immunoglobulin preparations.

von Gunten S, Schaub A, Vogel M, Stadler BM, Miescher S, Simon HU.

Blood. 2006 Dec 15;108(13):4255-9. Epub 2006 Aug 10.

PMID:
16902148

Supplemental Content

Loading ...
Support Center